MORC3 and dermatomyositis: Antibodies against NXP-2 are predominantly observed in patients with dermatomyositis and juvenile dermatomyositis; however, the case of anti-NXP-2-positive immune-mediated necrotizing myopathy was also reported [68,69,70].